CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX) IN PATIENTS WITH STAGE II COLON CANCER- MEDICAL AND ECONOMIC BENEFITS
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61195-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)61195-3/fulltext
Title :
CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX) IN PATIENTS WITH STAGE II COLON CANCER- MEDICAL AND ECONOMIC BENEFITS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61195-3&doi=10.1016/S1098-3015(10)61195-3
First page :
Section Title :
Open access? :
No
Section Order :
3